Mefund Capital
Med-Fine Capital is a Venture Capital firm focused on healthcare and bio-science industry.
Business Model:
Revenue: $0
Employees: 0-0
Rankings
Industries / Tags:
Detailed Mefund Capital Information
Geographic Data
Address:
City:
State:
Zip:
Country:
Financial Info
Stage:
Raised Last:
$0
Raised Total:$0
Social
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Founded in 2014 at the China’s financial hub-Shanghai, Mefund Capital is a young investment fund. Mefund owns holdings of Shanghai Mefund Capital and Mefund Capital Management (Beijing), and is a shareholder of Noajin Asset Management.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 8/2021 | Zhongguancun Shuimu Medical Technology | Series A | - |
| 1/2022 | Westlake Omics | Seed Round | - |
| 8/2021 | LYNK Pharmaceuticals | Series B | 0 |
| 2/2022 | CorrGene | Seed Round | 0 |
| 1/2020 | Alebund Pharmaceuticals | Series A | - |
| 1/2017 | Mabworks | Series B | 39.2M |
| 5/2016 | Mabworks | Series A | 15.3M |
| 3/2021 | Artivila Therapeutics | Seed Round | 22.8M |
| 5/2021 | Alebund Pharmaceuticals | Series B | 0 |
| 10/2020 | ClinBrain | Series B | 14.9M |
| 2/2019 | Oceanus Plus | Series A | - |
| 5/2018 | Zion Pharma | Angel Round | 2.8M |
| 4/2022 | Med-Vision | Series A | 3.1M |
| 3/2019 | ZD Medtech | Seed Round | - |
| 11/2018 | Weimi Bio-Tech | Series A | - |
| 9/2021 | Immunophage Biotech | Series A | - |
| 7/2020 | Zhongyianke Biotech | Series B | - |
| 10/2020 | PharmaLegacy Laboratories (Shanghai) Co., Ltd. | Series B | - |
| 9/2020 | VitaVitro Biotech | Series C | 15.5M |
| 10/2021 | Epintek | Series C | - |
| 4/2018 | Julu Medical | Series A | - |
| 10/2021 | Med-Vision | Series A | - |
| 1/2023 | Med-Vision | Series A | - |
| 5/2018 | ChosenMed | Series A | - |
| 11/2020 | Allorion Therapeutics | Seed Round | - |
| 4/2020 | ChosenMed | Series B | 14M |
| 7/2021 | Leadinno Medical Valley | Series A | - |
| 1/2019 | Cherubs | Series A | 3M |
| 4/2020 | LYNK Pharmaceuticals | Series A | - |
| 3/2020 | Ranok Therapeutics | Seed Round | 10M |
| 7/2019 | MagAssist | Series A | - |
| 5/2022 | Weimi Bio-Tech | Series B | 16.4M |
| 8/2018 | Gaugene | Angel Round | 3M |
| 11/2020 | Alebund Pharmaceuticals | Series A | - |
| 12/2021 | AccuPulse | Seed Round | 0 |
| 10/2021 | PharmaLegacy Laboratories (Shanghai) Co., Ltd. | Series C | - |
| 3/2019 | Leto Laboratories | Series A | 3M |
| 9/2018 | Eccogene | Series A | 14.6M |
| 1/2019 | Immvira | Series A | 15M |
| 12/2016 | Biosis Healing | Series B | 11.5M |
| 9/2022 | Leadinno Medical Valley | Series A | 14.4M |
| 10/2020 | BioNova Pharma | Series B | 25M |
| 6/2022 | Degron Therapeutics | Series A | 0 |
| 3/2018 | LYNK Pharmaceuticals | Angel Round | 10M |
| 1/2019 | Zion Pharma | Series A | 11.9M |
| 8/2020 | Zion Pharma | Series A | 20M |
| 8/2018 | Shunzhi Technology | Angel Round | 1.5M |
| 3/2020 | ExcelMab | Series A | 1.4M |
| 8/2020 | Hanyu Medical | Series D | 0 |
| 7/2021 | Zion Pharma | Series B | 40M |
| 11/2021 | Allorion Therapeutics | Series A | 0 |
| 9/2017 | Hanyu Medical | Series A | - |
| 6/2022 | Degron Therapeutics | Series A | 0 |
| 2/2022 | CorrGene | Seed Round | 0 |
| 1/2022 | Westlake Omics | Seed Round | - |
| 12/2021 | AccuPulse | Seed Round | 0 |
| 11/2021 | Allorion Therapeutics | Series A | 0 |
| 10/2021 | Med-Vision | Series A | - |
| 10/2021 | Epintek | Series C | - |
| 9/2021 | Immunophage Biotech | Series A | - |
| 8/2021 | LYNK Pharmaceuticals | Series B | 0 |
| 5/2021 | Alebund Pharmaceuticals | Series B | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
